On the Pulse of
Precision
Cancer

Treatment

Mirai Medical logo white
Medical professional examining a patients back and neck area

Skin Therapy

Delivered under local anaesthesia as a day case procedure, ePORE® therapy can be used in combination with chemotherapy for the local control of a wide range of skin cancers.
Scan of Gastrointestinal Therapy

Gastrointestinal Therapy

ePORE® therapy is a precision cancer treatment addressing critical unmet challenges and symptom relief for gastrointestinal cancers.

How It Works

Dr Declan Soden's mission speech in graphic

Addressing critical unmet challenges in global skin and gastrointestinal cancer treatment.

GI cancers account for 26% of the global cancer incidence and 35% of all cancer related deaths in 2018.
M. Arnold, "Global Burden of 5 Major Types of Gastrointestinal Cancer", Gastroenterology, no. https://doi.org/10.1053/j.gastro.2020.02.068, 2020.
By 2040, the global number of new cases of GI cancers are predicted to increase by 58% to 7.5 million.
M. Arnold, “Global Burden of 5 Major Types Of Gastrointestinal Cancer,” Gastroenterology, no. https:// doi.org/10.1053/j.gastro.2020.02.068, 2020
By 2040, global numbers of deaths from GI cancers are predicted to increase by 73% to 5.6 million.
M. Arnold, “Global Burden of 5 Major Types Of Gastrointestinal Cancer,” Gastroenterology, no. https:// doi.org/10.1053/j.gastro.2020.02.068, 2020.
In the UK, operating theater running costs are a median of £16 per minute. ePORE® therapy can be performed as a day case procedure in < 1 hour.
Volpin A, Khan O, Haddad F. Theater Cost Is £16/Minute So What Are You Doing Just Standing There?. J Arthroplasty. 2016;31(1):22-26. doi:10.1016/j.arth.2015.08.008

Targeted Therapy. Big Results.

Icon depicting improved patient experience

Improved Patient Experience

  1. Precision-based technology, so only targets tumour tissue, thereby preserving healthy tissue
  2. Minimal side effects
  3. Reduces/stops bleeding associated with GI cancers
  4. Preserves cosmesis and function of treated area
Icon of a hand holding cash

Cost effective

  • Can be performed under local anaesthetic therefore reducing cost associated with the procedure
  • Patients are treated as a day-case procedure which reduces time spent in hospital
Icon of a hand holding a lightbulb

An alternative treatment option

  • For those who are at risk of going under general anaesthetic or suffer with comorbidities
  • Can be used in conjunction with other standard treatments (chemotherapy, surgery)
  • Repeatable treatment

Years of Experience

We bring together some of the best minds in electroporation and therapeutic development expertise.

DR Declan Soden Founder & CEO of Mirai Medical
Dr. Declan Soden
Founder & Chief Executive Officer
Colin Forde
Chief Operating Officer
Simon Ombler, sales and marketing director at Mirai Medical
Simon Ombler
Sales & Marketing Director
Seán Kinsella, CTO of Mirai Medical
Seán Kinsella
Chief Technical Officer

Follow Our Progress